Sponsored Content
4POTENTIA® highlights the limitations of traditional DIM, including poor solubility and inconsistent absorption. Its solubilized DIM ingredient, Bio-DiMax®, significantly improves bioavailability—allowing for lower doses, enhanced tolerability, and more predictable results to support advanced hormone, detox, and metabolic health formulations for modern nutraceutical brands.
At 4POTENTIA®, we're committed to elevating ingredient science from academic insight to real-world impact. That commitment is on full display in our latest white paper, "Advancing DIM Bioavailability Through Solubilized Formulation," published in SupplySide Supplement Journal.
This paper tackles one of the most persistent challenges in botanical formulation: improving systemic exposure of diindolylmethane (DIM)—a compound renowned for its influence on hormone metabolism, immune pathways, and cellular balance—which historically suffers from poor aqueous solubility and inconsistent absorption.

The problem with traditional DIM
DIM is naturally derived from cruciferous vegetables and valued for its role in estrogen and androgen pathways, detoxification support, and broader homeostatic functions. However, its potential has been limited by a fundamental pharmaceutical issue: DIM's low solubility in water results in variable absorption and unpredictable systemic exposure. This means that even well-designed products may deliver inconsistent results if the active compound never reaches effective levels in the body.
Why formulation science matters more than dose
The white paper underscores a critical insight: delivery technology matters at least as much as the dose itself. Through state-of-the-art pharmaceutical formulation techniques originally honed for poorly soluble drugs, researchers have turned DIM from a compound with low uptake into one with far more predictable bioavailability profiles.
Rather than relying on high dose levels to chase effects—a strategy that can exacerbate tolerability issues and increase cost—solubilized formulations focus on consistent uptake at lower functional doses, which supports both consumer experience and regulatory strategy.
What you'll discover inside the white paper
Our white paper walks through key scientific and formulation topics, including:
From paper to product: connecting the dots to Bio-DiMax®
The insights in this white paper laid the foundation for Bio-DiMax®, 4POTENTIA®'s patent-protected DIM ingredient engineered for high bioavailability and reliable performance in finished products across categories.
By harnessing lessons from solubilized delivery science—and applying them within dietary supplement-friendly technology—Bio-DiMax® aims to set a new industry standard for DIM performance without resorting to excessive dosages or compromise in formulation design.
Why this matters for brands and formulators
Today's consumers demand products that work consistently and that can stand up to scrutiny from regulators, practitioners, and discerning users alike. This white paper doesn't just outline a scientific problem—it provides a roadmap for achieving real improvements in both product experience and formulation success.
If your brand is exploring hormonal health, detoxification, liver support, or multi-system wellness platforms, understanding how solubilized DIM changes the narrative is an essential step toward meaningful innovation.
To get access to the white paper, go to the 4POTENTIA® documents section in the company profile.
23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more